Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Breast Cancer|Progressive Breast Cancer
Interventions: DRUG: carboplatin|DRUG: bevacizumab|DRUG: herceptin
Sponsor: Dana-Farber Cancer Institute
Collaborators: Brigham and Women's Hospital|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Genentech, Inc.